Written questions by Jogee.

Which Minister attended the 2025 Commonwealth Health Ministers Meeting; and what assessment he has made of the potential implications for his policies of outcomes from that meeting.

The Parliamentary Under-Secretary of State for Public Health and Prevention attended the 2025 Commonwealth Health Ministers Meeting on 17 May 2025. The meeting was an opportunity for the United Kingdom and our Commonwealth partners to exchange views and strengthen cooperation on shared health challenges.Commonwealth health ministers adopted an Outcome Statement outlining commitments to build equitable, resilient, and sustainably financed health systems that prioritise vulnerable member countries, that the UK supported. The statement included several UK health priorities including cancer, digital health, mental health, and antimicrobial resistance.

What assessment he has made of the link between lung health and (a) air pollution and (b) indoor air quality in (i) Newcastle-under-Lyme constituency and (ii) Staffordshire.

Poor air quality is one of the largest environmental risks to public health in the United Kingdom. Epidemiological studies have shown that long-term exposure to air pollution, over years or lifetimes, reduces life expectancy, due to cardiovascular and respiratory diseases and lung cancer. Short-term exposure, over hours or days, to elevated levels of air pollution can also cause a range of health impacts, including effects on lung function, exacerbation of asthma, increases in respiratory and cardiovascular hospital admissions, and mortality. Further information is available at the following link: https://www.gov.uk/government/publications/health-matters-air-pollution/health-matters-air-pollution

What assessment he has made of trends in the level of the uptake of vaccines by children from ethnic minority communities in England.

The UK Health Security Agency (UKHSA) monitors trends in the level of childhood vaccination rates by upper tier local authority (UTLA), region, and country. The UKHSA does not routinely collect data on trends in the level of the uptake of vaccines by children from ethnic minority communities in England. An assessment of coverage trends and ethnicity was published in the Lancet in 2023, and is available at the following link:https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(23)00458-3/fulltextData on the coverage of all routine childhood immunisations is published quarterly by the UKHSA, and is available at the following link:https://www.gov.uk/government/statistics/cover-of-vaccination-evaluated-rapidly-cover-programme-2024-to-2025-quarterly-dataAnnual coverage data is also published by NHS England, and is available at the following link:https://digital.nhs.uk/data-and-information/publications/statistical/nhs-immunisation-statistics/england-2023-24

What assessment he has made of trends in the level of the uptake of vaccines by children in (a) Newcastle-under-Lyme constituency and (b) Staffordshire.

The UK Health Security Agency (UKHSA) monitors trends in the level of childhood vaccination rates by upper tier local authority (UTLA), region and country level. Newcastle-under-Lyme falls within the Staffordshire UTLA.In Staffordshire, children aged five years old in 2023/2024 had a 94.8% coverage for the first dose of the Measles, Mumps, and Rubella (MMR) vaccine. This is a 0.7 percentage point decrease from 2022/2023, when the coverage was 95.5% but is 3.6 percentage points above the England average which was 91.9%.Coverage of the 6-in-1 vaccine, which includes diphtheria, tetanus, pertussis also known as whooping cough, polio, Haemophilus influenzae type b (Hib) and hepatitis B, in the same age group was 95.6% in 2023/2024, a 0.7 percentage point decrease from 96.3% in 2022/2023 but 3.7 percentage points above the England average of 92.6%.Data on coverage of all routine childhood immunisations are published quarterly by UKHSA and annually by NHS England, and are available at the following links:https://www.gov.uk/government/statistics/cover-of-vaccination-evaluated-rapidly-cover-programme-2024-to-2025-quarterly-datahttps://digital.nhs.uk/data-and-information/publications/statistical/nhs-immunisation-statistics/england-2023-24

What recent steps he has taken to improve (a) maternity safety and (b) prevent brain injuries during childbirth.

NHS England is currently delivering a three-year plan for maternity and neonatal services, which brings together recommendations from previous independent inquiries, and sets national measures to make care safer, more personalised and more equitable. Significant improvements have been made through the plan, including the roll out of maternal mental health services, implementation of Version 3 of the Saving Babies Lives Care Bundle, establishment of 14 maternal medicine networks across England, and Equity and Equality Action Plans being published by all local areas to tackle inequalities for women and babies from ethnic backgrounds.To prevent brain injuries during childbirth, the Department has invested £7.8 million to develop the Avoiding Brain Injury in Childbirth programme which will reduce the number of avoidable brain injuries that occur during childbirth. This will be implemented by NHS England and will provide staff with the tools and right training to identify, intervene and manage obstetric emergencies as well as identifying and better identify signs that the baby is showing distress during labour.Additionally, the Maternity and Newborn Safety Investigations (MNSI) Programme investigates certain cases of potential severe brain injury that occur in the first seven days of life. MNSI investigations seek to improve maternity safety and reduce the prevalence of adverse outcomes through providing learning to the health system via reports at a local, regional and national level.

When the next meeting of the NHS England Clinical Priorities Advisory Group (CPAG) will take place; and what steps the Government plans to take to fund treatments previously reviewed by CPAG.

The NHS England Clinical Priorities Advisory Group (CPAG) continues to meet on a monthly basis to consider policy propositions and service specification propositions that are categorised as in year service. The next scheduled meeting was due for 4 June 2025. The further review of treatments previously considered by CPAG that require significant investment will be deferred until such point that recurrent revenue funding can be identified to support new discretionary spend commitments.

What recent steps he has taken to increase the level of access to NHS dentists by people in a) Newcastle-under-Lyme and (b) Staffordshire.

The Government plans to tackle the challenges for patients trying to access National Health Service dental care with a rescue plan to provide 700,000 more urgent dental appointments and recruit new dentists to the areas that need them most. To rebuild dentistry in the long term, we will reform the dental contract with the sector, with a shift to focus on prevention and the retention of NHS dentists.The responsibility for commissioning primary care services, including NHS dentistry, to meet the needs of the local population has been delegated to the integrated care boards (ICBs) across England. For the Newcastle-under-Lyme constituency and Staffordshire, this is the Staffordshire and Stoke-on-Trent ICB. ICBs have been asked to start making extra urgent dental appointments available from April 2025. The Staffordshire and Stoke-on-Trent ICB is expected to deliver 16,190 additional urgent dental appointments as part of the scheme.

What estimate he has made of the number of children and young people waiting for an ADHD assessment in (a) Newcastle-under-Lyme and (b) Staffordshire.

There is, at present, no single established dataset that can be used to monitor waiting times for assessment and diagnosis for attention deficit hyperactivity disorder (ADHD) for individual organisations or geographies in England. Although the data requested is not held centrally, it may be held locally by individual National Health Service trusts or commissioners.For the first time, NHS England published management information on ADHD waits at a national level on 29 May 2025 as part of its ADHD data improvement plan; it will soon release technical guidance to integrated care boards (ICBs) to improve recording of ADHD data, with a view to improving the quality of ADHD waits data and publishing more localised data in future.NHS England has established an ADHD taskforce which is bringing together those with lived experience with experts from the NHS, education, charity and justice sectors to get a better understanding of the challenges affecting those with ADHD, including in accessing services and support, with the report expected in the summer. NHS England has also captured examples from ICBs who are trialling innovative ways of delivering ADHD services and is using this information to support local systems to tackle ADHD waiting lists and provide support to address people’s needs.

If he will make an assessment of the potential implications for his policies of the report by Asthma Lung UK entitled Lung conditions kill more people in the UK than anywhere in Western Europe, published on 28 February 2022.

The report from Asthma + Lung UK highlights the relatively high mortality rate in the United Kingdom from lung conditions such as chronic obstructive pulmonary disease (COPD) and asthma. It asks for better and faster diagnosis, new treatments, new technology, and more action on prevention. These are consistent with the Government’s policies and priorities.The Government has committed to delivering three big shifts that the National Health Service needs to be fit for the future: from hospital to community, from analogue to digital, and from sickness to prevention. All of these are relevant to improving respiratory health in all parts of the country.This will support earlier diagnosis, better joint working between services, and greater use of apps and wearable technology will all help people manage their long-term conditions, including respiratory conditions, closer to home. Earlier diagnosis of conditions will help prevent deterioration and improve survival rates. Taking action to reduce the causes of the biggest killers, such as enabling a smoke free generation through the Tobacco and Vapes Bill, can further help prevent lung conditions.On COPD and asthma specifically, the NHS is investing in the provision of more and better rehabilitation services for respiratory patients. This has the objective of improving outcomes through early diagnosis including via spirometry tests, and through increased access to treatments.The NHS RightCare COPD pathway has been rolled out nationally and defines the optimal service for people with COPD. Furthermore, the National Respiratory Audit Programme aims to improve quality of care, services, and clinical outcomes for patients with asthma and COPD, by collecting and providing data on a range of indicators and pulmonary rehabilitation activity. A national programme of work is underway to support systems with improving access to Pulmonary Rehabilitation for the eligible population. Pulmonary rehabilitation is effective for people with COPD, improving exercise capacity or increased quality of life in 90% of patients who complete a programme.

What estimate she has made of the number of people with chronic obstructive pulmonary disease in (a) Newcastle-under-Lyme constituency and (b) Staffordshire.

The House of Commons Library has published estimates at a constituency level for a variety of health conditions, including chronic obstructive pulmonary disease (COPD), with further information available at the following link: https://commonslibrary.parliament.uk/constituency-data-how-healthy-is-your-area/ For the Newcastle-under-Lyme constituency, this data shows an estimated prevalence of 2.45% for COPD. This is higher than the estimated prevalence for the West Midlands and England, with both having a prevalence of 1.85%. These figures are based on modelled estimates, derived from data published by NHS Digital in the Quality and Outcomes Framework (QOF) 2022/23. Integrated care board (ICB) level QOF data for the same 2022/23 period is available at the following link: https://digital.nhs.uk/data-and-information/publications/statistical/quality-and-outcomes-framework-achievement-prevalence-and-exceptions-data/2022-23 This shows that for the NHS Staffordshire and Stoke-on-Trent ICB, the COPD register consists of 26,564 patients, and has a prevalence rate of 2.24%. The latest QOF data that has been published by NHS England is for the 2023/24 period, and is available at the following link: https://digital.nhs.uk/data-and-information/publications/statistical/quality-and-outcomes-framework-achievement-prevalence-and-exceptions-data/2023-24This shows that for the NHS Staffordshire and Stoke-on-Trent ICB, the COPD register consists of 27,019 patients, and has a prevalence rate of 2.26%.

What assessment he has made of the link between lung health and the adequacy of smoking cessation services in (a) Newcastle-under-Lyme constituency and (b) Staffordshire.

We are increasing our efforts to support smokers to quit and have invested an additional £70 million, this year and last, for local stop smoking services, in England. It is for local authorities to determine and commission the most appropriate stop smoking services for their area.No specific assessment has been made of the impact of stop smoking services on lung health in these areas. However, we have commissioned an independent evaluation of the impact of our additional funding to stop smoking services, in which we look at partnerships with health providers.There is also an established referral pathway between the NHS Targeted Lung Health Programme in University Hospital North Midlands and the local stop smoking service. The local NHS Targeted Lunch Health Check Programme also previously ran a pilot to offer smoking cessation support to patients through community pharmacies.

What assessment he has made of the potential impact of the Terminally Ill Adults (End of Life) Bill on the NHS budget.

I refer the hon. Member to the impact assessment.

What estimate he has made of the potential cost to the public purse of the Terminally Ill Adults (End of Life) Bill.

I refer the hon. Member to the impact assessment.

Whether he has discussed the Terminally Ill Adults (End of Life) Bill with his counterpart in the Welsh Government.

The Government remains neutral on the matter of assisted dying and the passage of the Terminally Ill Adults (End of Life) Bill. The Bill remains a matter for the hon. Member for Spen Valley who, as its sponsor, leads on policy and engagement in relation to the Bill.Ministers in the Department have had no discussions about the Bill with counterparts in the Welsh Government.

If he will support the aims of Age Without Limits Day.

Age Without Limits Day is the Centre for Healthy Aging’s event which aims to challenge ageism across the country through community and workplace activities. More information is available at the following link:https://www.agewithoutlimits.org/about-the-campaignThe Department is committed to improving outcomes for older people through a range of cross-cutting strategies and initiatives. It is embedding a focus on health inequalities across its work, including through the Core20PLUS5 approach in the National Health Service, which includes older age-related conditions such as dementia. It is also supporting improvements in adult social care to promote choice and to help people live as independent and fulfilling lives as possible.

Whether his Department is taking steps to help tackle ageism in healthcare services.

The Department is committed to improving outcomes for older people through a range of cross-cutting strategies and initiatives.Addressing healthcare inequalities is a fundamental part of the Health Mission and the 10-Year Health Plan, to ensure the National Health Service is there for anyone who needs it, whenever they need it. The Plan will be published in summer 2025 and aims to deliver on the three big shifts needed to move healthcare from hospital to the community, analogue to digital, sickness to prevention. This includes how services can be better integrated and tailored to improve quality of life and reduce inequalities in later life.The Department is embedding a focus on health inequalities across its work, including through the Core20PLUS5 approach in the NHS, which includes older age-related conditions such as dementia. It is also supporting improvements in adult social care to promote choice and to help people live as independent and fulfilling lives as possible.

What assessment he has made of the potential impact of levels of deprivation on lung health in (a) Newcastle-under-Lyme constituency, (b) Staffordshire and (c) England.

The 10-Year Health Plan will deliver the three big shifts our National Health Service needs to be fit for the future: from hospital to community; from analogue to digital; and from sickness to prevention. All of these are relevant to improving respiratory health in all parts of the country.More tests and scans delivered in the community will allow for earlier diagnosis, better joint working between services, and greater use of apps and wearable technology will all help people manage their long-term conditions, including respiratory conditions, closer to home. Earlier diagnosis of conditions will help prevent deterioration and improve survival rates.The prevalence of smoking in adults, current smokers who are 18 years old and over, in Newcastle under Lyme and Staffordshire is lower than the overall England average, at 8.8% and 9.0% respectively, compared to the overall England average of 12.4%.Urgent cancer referrals for suspected lung cancer in the Staffordshire and Stoke Integrated Care Board are much higher than the England average. However, the mortality rate from lung cancer, chronic obstructive airways disease, heart disease, and stroke associated with smoking in Staffordshire is similar to the England average.We are taking action to reduce the causes of the biggest killers, for instance by enabling a smoke free generation to further help prevent lung conditions.It is the most disadvantaged who suffer the most from the financial and health burden of smoking, with 230,000 households living in smoking induced poverty and with smoking being the number one preventable cause of death, disability, and ill health, claiming the lives of approximately 80,000 people a year in the United Kingdom, and being the leading cause of lung cancer. The landmark Tobacco and Vapes Bill will create the first smoke-free generation, ending the cycle of addiction and disadvantage and putting us on track to a smoke-free UK.

Whether the national cancer plan will include policies on equitable access to companion diagnostics for all (a) regions and (b) patient groups.

The National Cancer Plan will include further details on how we will improve outcomes for cancer patients, as well as speeding up diagnosis and treatment, ensuring patients have access to the latest treatments and technology, and ultimately bringing this country’s cancer survival rates back up to the standards of the best in the world.The plan will look at how we can maximise our impact through the most up-to-date technology and innovations. It will ensure that we continue to maximise the access to, and the impact of, clinical trials in diagnostics and treatments, building on the success of projects such as the NHS Cancer Vaccine Launch Pad. The plan will also consider mechanisms to accelerate the adoption of innovative diagnostics and treatments into the National Health Service, and will seek to ensure that high quality care is available to patients across the country.Furthermore, reducing barriers of entry to care and improving the efficiency of patient pathways are essential to improving cancer outcomes and experiences. The plan will explore how we can improve data collection, sharing, and analysis, to help identify variation and blockages in the pathway and develop solutions with the NHS.

Whether the national cancer plan will include policies on improving the (a) collection, (b) sharing and (c) analysis of data for all cancer types to help (i) identify (A) variation and (B) blockages in the pathway and (ii) develop solutions with the NHS.

The National Cancer Plan will include further details on how we will improve outcomes for cancer patients, as well as speeding up diagnosis and treatment, ensuring patients have access to the latest treatments and technology, and ultimately bringing this country’s cancer survival rates back up to the standards of the best in the world.The plan will look at how we can maximise our impact through the most up-to-date technology and innovations. It will ensure that we continue to maximise the access to, and the impact of, clinical trials in diagnostics and treatments, building on the success of projects such as the NHS Cancer Vaccine Launch Pad. The plan will also consider mechanisms to accelerate the adoption of innovative diagnostics and treatments into the National Health Service, and will seek to ensure that high quality care is available to patients across the country.Furthermore, reducing barriers of entry to care and improving the efficiency of patient pathways are essential to improving cancer outcomes and experiences. The plan will explore how we can improve data collection, sharing, and analysis, to help identify variation and blockages in the pathway and develop solutions with the NHS.

What steps his Department is taking to streamline diagnostics pathways for (a) companion and (b) other diagnostics.

The Elective Reform Plan, published in January 2025, announced that the integrated care boards (ICBs) will make optimal use of the new diagnostic capacity by implementing the new standards for community diagnostic centres (CDCs) and hospital-based diagnostic services, in particular increasing direct referrals and rolling out at least 10 straight-to-test pathways by March 2026.To date, NHS England has agreed three national CDC diagnostic pathways which ICBs will be expected to implement by March 2026. These are: breathlessness; children and young people’s asthma; and unscheduled bleeding on hormone replacement therapy.NHS England is working with clinicians to best determine other priority straight to test pathways, including in CDCs. Implementation of these pathways will deliver the expectations in the Elective Reform Plan for significant elective care reform to be delivered in at least five specialties, those being: ear nose and throat; gastroenterology; respiratory; urology; and cardiology. Wider clinical pathway optimisation work will also centre around these specialities.The National Cancer Plan will include further details on how we will improve outcomes for cancer patients, as well as speeding up diagnosis and treatment, ensuring patients have access to the latest treatments and technology, and ultimately bringing this country’s cancer survival rates back up to the standards of the best in the world.  The plan will also look at how we can maximise our impact through the most up-to-date technology and innovations. It will ensure that we continue to maximise the access to, and the impact of, clinical trials in diagnostics and treatments.